Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$63.41
-0.29-0.46%
Last update: 3:16 PM
15 minutes delayed
Comments
Loading...
Overview Rating
Speculative
Incyte (NASDAQ:INCY) Stock Quotes, Forecast and News Summary
Incyte Stock (NASDAQ: INCY) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Incyte (INCY) stock?
You can purchase shares of Incyte (NASDAQ:INCY) through any online brokerage.
Who are Incyte (INCY) competitors?
Other companies in Incyte’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
What is the forecast, or price target, for Incyte (INCY) stock?
Incyte has a consensus price target of $75.68.
What is the current price for Incyte (INCY)?
The stock price for Incyte (NASDAQ: INCY) is $63.91 last updated September 25, 2024 at 7:39 AM EDT.
Does Incyte (INCY) pay a dividend?
There are no upcoming dividends for Incyte.
When is Incyte (NASDAQ:INCY) reporting earnings?
Incyte’s Q3 earnings are confirmed for Tuesday, October 29, 2024.
Is Incyte (INCY) going to split?
There is no upcoming split for Incyte.
What sector and industry does Incyte (INCY) operate in?
Incyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.